sábado, 6 de noviembre de 2021

Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial - EClinicalMedicine

Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial - EClinicalMedicine

No hay comentarios:

Publicar un comentario